Download presentation
Presentation is loading. Please wait.
1
Heart Rhythm Disorders
Dr Husain Shabeeh Consultant Cardiologist & Cardiac Electrophysiologist Croydon University Hospital and King’s College Hospital
2
My interests Diagnosis and management of heart rhythm disorders
Electrophysiology studies and ablation for AF, SVT, VT Cardiac devices including PPM, ICD, CRT, ILR Syncope
3
Agenda Atrial fibrillation SVT Atrial flutter Syncope
Anything else you would like to discuss…
4
Atrial Fibrillation
5
William Harvey Circulation of the Blood (1628)
“It is...evident that the auricles pulsate, contract...and eject the blood into the ventricles. [The auricle] has to help infuse blood into the ventricle so that [the ventricle] may send it on with greater vigour” First physician to describe completely the systemic circulation
6
Loss of P waves Atrial activity (‘f’ waves) ‘rate’ bpm Irregular ventricular response (unless heart block or VT)
7
AF – who, when and why? Affects 1-2% of population (over 10% in 80+)
2/3 of patients with AF are aged 65-85 Lifetime risk 25% for individuals over 40y (or 1 in 4!) Causes/associations Male gender, age Hypertension, heart failure, valvular heart disease, ischaemic heart disease, thyroid dysfunction, diabetes, alcohol excess Obesity, OSA Acutely: sepsis, surgery, stress, electrolyte loss, binge drinking Other arrhythmias (e.g. WPW) especially in young
8
AF is harmful because… Thromboembolism Haemodynamics
Anti-coagulants can reduce this risk by 50-70% Haemodynamics Loss of atrial component of filling Irregular ventricular rhythm High ventricular rates (AV nodal drugs can help with this one only)
9
AF leads to… Relative mortality risk 1.5-2.0
5-fold increase in ischaemic stroke 20-30% of all strokes are due to AF cognitive decline / vascular dementia Increased hospitalisation / healthcare costs 1% of total healthcare spending in UK (currently) Symptoms / QoL: palpitations, breathlessness, exercise incapacity, chest pain, syncope… Heart failure (cause and/or exacerbator)
10
AF detection / screening
Pulse check ECG ECG monitoring (e.g. Holter) Prolonged ECG monitoring (e.g. patches, implantable recorders) Personal ECG recorders (e.g. AliveCor) Some patients have these!
11
Anticoagulation ESC guidelines 2016
12
Net clinical benefit NOACs vs. warfarin
Net clinical benefit and 95% CI of all treatment arms of non-vitamin K antagonist oral anticoagulants versus warfarin tested in phase III clinical trials for the weighed composite outcome of ischemic stroke + systemic embolism + myocardial infarction + hemorrhagic stroke + adjusted major bleeding (major bleeding minus hemorrhagic stroke). Net clinical benefit is expressed as ischemic stroke equivalents prevented per 100 person-years using ischemic stroke as the reference event (weight = 1). CI = confidence interval; IS = ischemic stroke; NNT = number needed to treat (to prevent all grouped events included in the net clinical benefit evaluation, per year of treatment); NOAC = non-vitamin K antagonist oral anticoagulant. Renda et al Am J Med. 2015
13
Case 1 74 female Asymptomatic Hypertensive
Routine visit to GP found to have irregularly irregular pulse ECG confirms AF with ventricular rate 110 What would you do?
14
Case 1 Rate control OAC Bloods? Echo? Holter? Refer to Cardiology?
Aim initial resting HR < 110 OAC CHADSVASc = 3 Bloods? Echo? Holter? Refer to Cardiology?
15
ESC guidelines 2016
16
Case 2 58 male Breathless for 4 months No PMHx Alcohol 30 units / week
Examination Pulse irregular Nil else ECG confirms AF, ventricular rate 120 What would you do?
17
Case 2 GP started Bisoprolol 2.5mg
Patient felt a little better with better heart rate control but still lethargic and breathless Asked patient to reduce alcohol intake (which he did!) Referred to cardiology Seen in cardiology clinic Echo: Mild LV dysfunction in AF, mild LA dilatation CHADSVASC = 0 Referred for DCCV, started on apixaban and amiodarone When came for DCCV found to be in SR. Switched to Flecainide, Bisoprolol and Apixaban lethargic and still has 1 hour episodes of PAF every week Referred to electrophysiologist for ablation.
18
Beyond electric shocks and poisons… can we cure AF?
ESC guidelines 2016
19
AF ablation AF ablation in symptomatic AF patients
instead of (or after failed/intolerable) drug therapy (note risk of medium-long term AAD) especially in patients with heart failure (ARC-HF, CASTLE-AF trials, etc.) emerging evidence of prognostic benefit of ablation-based rhythm control compared with rate control Particularly effective in paroxysmal and early persistent AF
20
AF ablation Pulmonary vein isolation (+/- other substrate modification for persistent AF) Success rates PAF: 70% SR at 1y off AAD after 2-3 procedures 80%-90% persistent AF: 40-50% at 1y, 70-80% with 2-3 ablations (reduced success LA size, duration of AF, structural heart disease e.g. HCM) Complication rates <1 in 1000 death <1 in 200 stroke <1 in 100 major bleeding Kuck K et al. N Engl J Med 2016;374:
21
Isolation of right pulmonary veins
24
Case 2 3 month follow-up OPA 12 months follow-up OPA
Well with no further episodes after the first few weeks post ablation. All meds stopped at this OPA (flecainide, bisoprolol, apixaban) 12 months follow-up OPA Remains well Discharged
25
Case 3 67 female Palpitations last 2 hours with SOB PMHx: Hypertensive
irregularly irregular pulse at 160 Feels clammy BP 90/60 What would you do?
26
Case 3 Unwell patient – refer to A&E Adverse features are for DCCV:
shock, syncope, ischaemia, heart failure
27
Current Croydon pathway – any comments?
28
Other arrhythmias
29
What are SVTs? AVNRT AVRT Atrial flutter Atrial tachycardia
Rare SVT syndromes Rare Accessory pathway Syndromes Permanent Junctional Reciprocating tachycardia (PJRT) Junctional ectopic tachycardia (JET) Narrow complex VT!
30
Case 3 34 female Fast regular palpitations every few weeks lasting 10 to 30 mins No PMHx Normal physical examination Normal ECG What would you do?
31
Case 3 Medications? Await symptom-ECG correlation?
Had longer episodes and presented to A&E on 2 occasions
32
SVT (AVNRT) ECG
33
AVNRT explanation
34
Treatment Medication -Used when attacks infrequent -Aim is to change the properties of the pathways so SVT can’t happen -Drugs that act on the AVN BB, Ca Channel blockers, digoxin -Drugs that change the speed of conduction – Flecainide -Don’t need OAC - ACUTE – vagal manoeuvres adenosine or BB Ablation For pts who are intolerant of medications or who have break through symptoms Success / cure rate >95% Main complication we worry about is PPM
35
Case 3 Slow pathway ablation for AVNRT
All medications stopped the same day as ablation OPC 3/12 – no symptoms, discharged
36
AVRT Due to an extra fibre of electrically conducting tissue in the heart / accessory pathway Pre-excitation / delta wave WPW Concealed accessory pathway
37
WPW / accessory pathway
38
Treatment WPW small risk of pre-excited AF and sudden death Medical Mx
Ablation Only curative strategy Aim is to find the accessory pathway and ablate it APs can be on the right side or the left side of the heart (TV or MV) Success (cure) rates >90-95%
39
Atrial Flutter Arrhythmia from the right atrium
Like AF in that it is fast and patients usually need to be on oral anticoagulation Has a characteristic ECG Heart rate in atrial flutter is usually 150bpm (2:1 AV conduction) pre rate control
40
Flutter (‘F’) waves at bpm Slow downstroke/rapid upstroke II/III/aVF (typical flutter) Often regular ventricular response (classically 150bpm 2:1 pre-rate control)
41
Treatment Ablation Only curative strategy Success rate >90%
Medical Anticoagulation (CHADSVASC score) Ventricular rate control Robust circuit so often doesn’t work. AV nodal blockers (BB, CaB) and conduction slowers (Flecainide) DCCV – successful but may not last. Ablation Only curative strategy Success rate >90% Comps 1% Painful so usually done with sedation Target is the Cavotricuspid annulus
42
Atrial flutter
43
Case 4 What would you do? 23 female
Episodes of light-headedness for last couple of years, but increasing frequency. Often in warm places (e.g. train), always standing. Has had a 6 episodes of LOC last 1 year, including injury to hand, and shorter warning. Quick recovery from LOC No tongue biting / incontinence / shaking No PMHx Normal physical examination Normal ECG Fairly active with work and young child What would you do?
44
Case 4 History consistent with vaso-vagal syncope
Current fluid intake: 2 glasses water 3 cups coffee Cola with lunch Advised: litres non-caffeinated, non-carbonated fluid Added salt to diet (6-9g / day) Counter-pressure maneuvers Lie down to avoid LOC! Improvement in symptoms but still having symptoms at next OPC as new job requires longer train journey
45
Case 4 Tilt table test Symptoms reproduced with documented hypotension consistent with vaso-vagal syncope Continued symptoms including LOC despite adhering to good fluid status Midodrine started with good effect Likely to improve over time (natural progression) and can reduce Midodrine once stable
46
Current CUH referral system:
Syncope Current CUH referral system: Refer to A&E Syncope associated with angina or known structural heart disease Syncope with abnormal ECG Refer to community clinic Recurrent dizziness or syncope Manage in primary care Suspected vaso-vagal syndrome responding to conservative measures AND no evidence of structural heart disease
47
Other…? Is there anything else you would like to discuss?
Any cases you would like to discuss? Any questions?
48
Summary AF Screening is vital to reduce risk esp. of stroke OAC
Rate +/- rhythm control Atrial flutter Treat similar to AF Catheter ablation very successful SVT Usually non-malignant and manage symptoms Pre-excitation on ECG means potentially dangerous especially if has symptoms Thank you!
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.